292 
Effects on Human B Lymphocytes of HIV-1-associated Host CD40 Ligand
Genevieve Martin*, J Roy, C Barat, C Gilbert, and M Tremblay
Ctr Hosp Univ Laval, Quebec City, Canada
Background: Several B-cell abnormalities are
seen following infection with HIV-1. However, the exact mechanisms of B-cell
dysfunction during HIV-1 infection are poorly understood. Having recently shown
that CD40L, the ligand for CD40, is inserted within budding
HIV-1 particles, we hypothesized that the contact between virus-anchored host
CD40L and CD40 on the surface of B lymphocytes might result in activation of
this cell type. Moreover, we wondered whether this additional interaction
between HIV-1 and B cells might facilitate an eventual virus transfer to more
susceptible target cells such as autologous CD4+
T lymphocytes.
Methods: Autologous
B cells and CD4+ T lymphocytes were isolated from human tonsils. Isogenic virions either lacking
(NL4-3/null) or bearing CD40L (NL4-3/CD40L) were produced by transient transfection of 293T cells. Virus preparations were
incubated first with purified B cells before performing virus binding, electrophoretic mobility shift and transmission assays.
Results: Attachment of NL4-3/CD40L virions to B lymphocytes was augmented compared to isogenic NL4-3/null viruses. Moreover, NL4-3 particles
bearing CD40L, but not viruses lacking host CD40L, induced the nuclear
translocation of NF-kB in B lymphocytes. The presence of host-derived
CD40L within HIV-1 envelope resulted in an enhanced infection of CD4+
T cells in trans
upon co-culture with B lymphocytes.
Conclusions:
Altogether the data gathered from this series of investigations suggest
that incorporation of host-encoded CD40L in HIV-1 might play a role in the
described B-cell abnormalities seen in infected individuals.
|